South America Cardiac Arrhythmia Monitoring Devices Market - Growth, Trends, and Forecasts (2017 - 2022)
In the year 2016, the North American cardiac arrhythmia monitoring devices market was valued at USD XX million and it is expected to reach a market value of USD XX million by the year 2021, growing at a CAGR of X.X% during the forecast period (2017 - 2022). Cardiac arrhythmia monitoring devices are extremely useful in tracking the heart function and report any abnormalities in normal function (rhythm). Hence, they not just help in maintaining a continuous record of heart function but have also proven to be life savers due to their ability to report abnormalities in normal heart function like in the case of a cardiac event. North America Cardiac Arrhythmia Monitoring Devices Market-Market Dynamics The increasing use of telecardiology along with the ease of use and portability of cardiac arrhythmia monitoring devices and the development of smart cardiac monitors are driving the growth of this market. While the dependency of signal amplitude and quality on factors that are not controlled by the devices along with unclear reimbursement policies and the high cost of remote cardiac arrhythmia monitoring are hindering the growth of this market. The lack of low-cost cardiac arrhythmia monitoring devices is currently a huge opportunity in this market, while the extensive infrastructural requirements preventing the entry of small players are currently the major challenges faced by this market. The North American cardiac arrhythmia monitoring devices market has been segmented on the basis of devices into cardiac telemetry devices, event monitoring devices, continuous rhythm monitoring devices and Holter monitoring devices. The market has been segmented on the basis of service providers into mobile cardiac telemetry monitoring service providers and independent diagnostic testing facilities/clinics. Based on geography, the market is segmented into the United States, Canada and Mexico. Some of the key players in the market are: Biotelemetry Cardiac Science Corp. Cardiocom Cardionet GE Healthcare What the Report Offers Market analysis for the North American cardiac arrhythmia monitoring devices market, with region-specific assessments and competition analysis on the global and regional scale. Market definition along with the identification of key drivers and restraints. Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale. Extensively researched competitive landscape section with profiles of major companies along with their market share. Identification and analysis of the macro and micro factors that affect the North American cardiac arrhythmia market on both global and regional scale. A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information. A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market. Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.